Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2013

Open Access 01-12-2013 | Short report

Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice

Authors: Lorenza Brocca, Anna Mascaro, Giuseppe D’Antona

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2013

Login to get access

Abstract

Background

Branched chain amino acid (BCAA) supplementation is a recently identified strategy to promote longevity in mice. A proteomic approach was used to identify proteins which are differentially expressed in the sera of mice following supplementation with selected branched chain amino acid enriched mixture (BCAAem).

Findings

12 male mice (C57Bl6, 9 months-old) were randomly assigned to unsupplemented (Control, n = 6) and supplemented (BCAA, n = 6, 0.1 mg/gr/day in drink water for 4 weeks). At the end of treatment total plasma samples from Control and BCAAem mice were separated by two-dimensional gel electrophoresis (2-DE). After staining, the gels were imaged and differential protein expression patterns were interrogated using image analysis software. Spots showing a different expression level were identified through a comparison with 2D maps found in databases officially recognized (ExPASy).
Master gels of Control and BCAA mice exhibited slightly different 2-DE patterns as only 10 spots out of 500 appeared differentially expressed: 8 were upregulated (corresponding to Apolipoprotein A-I (APOA1), Complement factor B, Complement C3, Immunoglobulin light chain) and 2 appeared downregulated (Alpha-1-antitrypsin and unknown).

Conclusions

Supplementation with BCAAem in mice results in a slight perturbation of the host serum proteome. Of particular interest is the increased Apolipoprotein A-I (APOAI) following treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Houtkooper RH, Williams RW, Auwerx J: Metabolic networks of longevity. Cell. 142: 9-14. Houtkooper RH, Williams RW, Auwerx J: Metabolic networks of longevity. Cell. 142: 9-14.
2.
go back to reference D’Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, Caliaro F, Corsetti G, Bottinelli R, Carruba MO, Valerio A, Nisoli E: Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010, 12: 362-372. 10.1016/j.cmet.2010.08.016.CrossRefPubMed D’Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, Caliaro F, Corsetti G, Bottinelli R, Carruba MO, Valerio A, Nisoli E: Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010, 12: 362-372. 10.1016/j.cmet.2010.08.016.CrossRefPubMed
3.
go back to reference Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA: Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr. 2004, 134 (6 Suppl): 1583S-1587S.PubMed Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA: Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr. 2004, 134 (6 Suppl): 1583S-1587S.PubMed
4.
go back to reference Bassit RA, Sawada LA, Bacurau RF, Navarro F, Martins E, Santos RV, Caperuto EC, Rogeri P, Costa Rosa LF: Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition. 2002, 18 (5): 376-379. 10.1016/S0899-9007(02)00753-0.CrossRefPubMed Bassit RA, Sawada LA, Bacurau RF, Navarro F, Martins E, Santos RV, Caperuto EC, Rogeri P, Costa Rosa LF: Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition. 2002, 18 (5): 376-379. 10.1016/S0899-9007(02)00753-0.CrossRefPubMed
5.
go back to reference De Palo EF, Gatti R, Cappellin E, Schiraldi C, De Palo CB, Spinella P: Plasma lactate, GH and GH-binding protein levels in exercise following BCAA supplementation in athletes. Amino Acids. 2001, 20 (1): 1-11. 10.1007/s007260170061.CrossRefPubMed De Palo EF, Gatti R, Cappellin E, Schiraldi C, De Palo CB, Spinella P: Plasma lactate, GH and GH-binding protein levels in exercise following BCAA supplementation in athletes. Amino Acids. 2001, 20 (1): 1-11. 10.1007/s007260170061.CrossRefPubMed
6.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMed
7.
go back to reference Glomset JA: The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968, 9: 155-167.PubMed Glomset JA: The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968, 9: 155-167.PubMed
8.
go back to reference Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ: Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation. 2003, 108: 661-663. 10.1161/01.CIR.0000086981.09834.E0.CrossRefPubMed Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ: Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation. 2003, 108: 661-663. 10.1161/01.CIR.0000086981.09834.E0.CrossRefPubMed
9.
go back to reference Yvan-Charvet L, Wang N, Tall AR: Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010, 30: 139-143. 10.1161/ATVBAHA.108.179283.PubMedCentralCrossRefPubMed Yvan-Charvet L, Wang N, Tall AR: Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010, 30: 139-143. 10.1161/ATVBAHA.108.179283.PubMedCentralCrossRefPubMed
10.
go back to reference Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991, 88: 2039-2046. 10.1172/JCI115532.PubMedCentralCrossRefPubMed Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991, 88: 2039-2046. 10.1172/JCI115532.PubMedCentralCrossRefPubMed
11.
go back to reference Garner B, Waldeck AR, Witting PK, Rye KA, Stocker R: Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem. 1998, 273: 6088-6095. 10.1074/jbc.273.11.6088.CrossRefPubMed Garner B, Waldeck AR, Witting PK, Rye KA, Stocker R: Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem. 1998, 273: 6088-6095. 10.1074/jbc.273.11.6088.CrossRefPubMed
12.
go back to reference Tall AR: Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med. 2008, 263: 256-273. 10.1111/j.1365-2796.2007.01898.x.CrossRefPubMed Tall AR: Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med. 2008, 263: 256-273. 10.1111/j.1365-2796.2007.01898.x.CrossRefPubMed
13.
go back to reference Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991, 353: 265-267. 10.1038/353265a0.CrossRefPubMed Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991, 353: 265-267. 10.1038/353265a0.CrossRefPubMed
14.
go back to reference Plump AS, Scott CJ, Breslow JL: Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1994, 91: 9607-9611. 10.1073/pnas.91.20.9607.PubMedCentralCrossRefPubMed Plump AS, Scott CJ, Breslow JL: Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1994, 91: 9607-9611. 10.1073/pnas.91.20.9607.PubMedCentralCrossRefPubMed
15.
go back to reference Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, Rader DJ: Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler Thromb Vasc Biol. 2003, 23: 1914-1920. 10.1161/01.ATV.0000092328.66882.F5.CrossRefPubMed Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, Rader DJ: Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler Thromb Vasc Biol. 2003, 23: 1914-1920. 10.1161/01.ATV.0000092328.66882.F5.CrossRefPubMed
16.
go back to reference Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS: ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res. 1998, 39: 313-321.PubMed Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS: ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res. 1998, 39: 313-321.PubMed
17.
go back to reference van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF: Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res. 2001, 42: 2077-2083.PubMed van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF: Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res. 2001, 42: 2077-2083.PubMed
18.
go back to reference Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003, 77: 1146-1155.PubMed Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003, 77: 1146-1155.PubMed
19.
go back to reference Ganji SH, Kamanna VS, Kashyap ML: Niacin and cholesterol: role in cardiovascular disease (review). J Nutr Biochem. 2003, 14: 298-305. 10.1016/S0955-2863(02)00284-X.CrossRefPubMed Ganji SH, Kamanna VS, Kashyap ML: Niacin and cholesterol: role in cardiovascular disease (review). J Nutr Biochem. 2003, 14: 298-305. 10.1016/S0955-2863(02)00284-X.CrossRefPubMed
20.
go back to reference Mooradian AD, Haas MJ, Wong NC: The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev. 2006, 27: 2-16.CrossRefPubMed Mooradian AD, Haas MJ, Wong NC: The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev. 2006, 27: 2-16.CrossRefPubMed
21.
go back to reference Dullens SP, Plat J, Mensink R: Increasing apoA-I production as a target for CHD risk reduction. Nutr Metab Cardiovasc Dis. 2007, 17: 616-628. 10.1016/j.numecd.2007.05.001.CrossRefPubMed Dullens SP, Plat J, Mensink R: Increasing apoA-I production as a target for CHD risk reduction. Nutr Metab Cardiovasc Dis. 2007, 17: 616-628. 10.1016/j.numecd.2007.05.001.CrossRefPubMed
22.
go back to reference Carroll MC: Complement and humoral immunity. Vaccine. 2008, Suppl 8: 28-33.CrossRef Carroll MC: Complement and humoral immunity. Vaccine. 2008, Suppl 8: 28-33.CrossRef
23.
go back to reference Phillips CM, Kesse-Guyot E, Ahluwalia N, McManus R, Hercberg S, Lairon D, Planells R, Roche HM: Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk. Atherosclerosis. 2012, 220: 513-519. 10.1016/j.atherosclerosis.2011.11.007.CrossRefPubMed Phillips CM, Kesse-Guyot E, Ahluwalia N, McManus R, Hercberg S, Lairon D, Planells R, Roche HM: Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk. Atherosclerosis. 2012, 220: 513-519. 10.1016/j.atherosclerosis.2011.11.007.CrossRefPubMed
24.
go back to reference Kolb WP, Morrow PR, Tamerius JD: Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm. 1989, 6: 175-204.PubMed Kolb WP, Morrow PR, Tamerius JD: Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm. 1989, 6: 175-204.PubMed
25.
go back to reference Duthie SJ, Horgan G, de Roos B, Rucklidge G, Reid M, Duncan G, Pirie L, Basten GP, Powers HJ: Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J Proteome Res. 2010, 9: 1941-1950. 10.1021/pr901103n.CrossRefPubMed Duthie SJ, Horgan G, de Roos B, Rucklidge G, Reid M, Duncan G, Pirie L, Basten GP, Powers HJ: Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J Proteome Res. 2010, 9: 1941-1950. 10.1021/pr901103n.CrossRefPubMed
26.
go back to reference Gmunder FK, Joller PW, Joller-Jemelka HI, Bechler B, Cogoli M, Ziegler WH, Muller J, Aeppli RE, Cogoli A: Effect of a herbal yeast food supplement and long-distance running on immunological parameters. Br J Sports Med. 1990, 24: 103-112. 10.1136/bjsm.24.2.103.PubMedCentralCrossRefPubMed Gmunder FK, Joller PW, Joller-Jemelka HI, Bechler B, Cogoli M, Ziegler WH, Muller J, Aeppli RE, Cogoli A: Effect of a herbal yeast food supplement and long-distance running on immunological parameters. Br J Sports Med. 1990, 24: 103-112. 10.1136/bjsm.24.2.103.PubMedCentralCrossRefPubMed
27.
go back to reference Hamilton KK, Zhao J, Sims PJ: Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9. J Biol Chem. 1993, 268: 3632-3638.PubMed Hamilton KK, Zhao J, Sims PJ: Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9. J Biol Chem. 1993, 268: 3632-3638.PubMed
28.
go back to reference Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007, 117: 746-756. 10.1172/JCI26206.PubMedCentralCrossRefPubMed Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007, 117: 746-756. 10.1172/JCI26206.PubMedCentralCrossRefPubMed
29.
go back to reference Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, Van Loveren H, Roholl P, Saito T, Verbeek JS, Claassens J, Koster AS, Nijkamp FP: Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med. 2002, 8: 694-701. 10.1038/nm722.CrossRefPubMed Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, Van Loveren H, Roholl P, Saito T, Verbeek JS, Claassens J, Koster AS, Nijkamp FP: Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med. 2002, 8: 694-701. 10.1038/nm722.CrossRefPubMed
30.
go back to reference Cohen G: Immunoglobulin light chains in uremia. Kidney Int. 2003, S15-S18. Cohen G: Immunoglobulin light chains in uremia. Kidney Int. 2003, S15-S18.
31.
go back to reference Cohen G, Horl WH: Free immunoglobulin light chains as a risk factor in renal and extrarenal complications. Semin Dial. 2009, 22: 369-372. 10.1111/j.1525-139X.2009.00582.x.CrossRefPubMed Cohen G, Horl WH: Free immunoglobulin light chains as a risk factor in renal and extrarenal complications. Semin Dial. 2009, 22: 369-372. 10.1111/j.1525-139X.2009.00582.x.CrossRefPubMed
32.
go back to reference Corsetti G, Stacchiotti A, D’Antona G, Nisoli E, Dioguardi FS, Rezzani R: Supplementation with essential amino acids in middle age maintains the health of rat kidney. Int J Immunopathol Pharmacol. 2010, 23: 523-533.PubMed Corsetti G, Stacchiotti A, D’Antona G, Nisoli E, Dioguardi FS, Rezzani R: Supplementation with essential amino acids in middle age maintains the health of rat kidney. Int J Immunopathol Pharmacol. 2010, 23: 523-533.PubMed
33.
go back to reference Pellegrino MA, Brocca L, Dioguardi FS, Bottinelli R, D’Antona G: Effects of voluntary wheel running and amino acid supplementation on skeletal muscle of mice. Eur J Appl Physiol. 2005, 93: 655-664. 10.1007/s00421-004-1237-8.CrossRefPubMed Pellegrino MA, Brocca L, Dioguardi FS, Bottinelli R, D’Antona G: Effects of voluntary wheel running and amino acid supplementation on skeletal muscle of mice. Eur J Appl Physiol. 2005, 93: 655-664. 10.1007/s00421-004-1237-8.CrossRefPubMed
Metadata
Title
Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice
Authors
Lorenza Brocca
Anna Mascaro
Giuseppe D’Antona
Publication date
01-12-2013
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-10-19

Other articles of this Issue 1/2013

Journal of the International Society of Sports Nutrition 1/2013 Go to the issue